In the present study, we describe the establishment of a hiPSC-based PCD in vitro disease model using patient lines containing mutations in the most frequently mutated and well-described PCD-associated gene DNAH5 [41,42], and in the recently PCD-associated described gene NME5 [36], respectively. The gene discussed is DNAH5; the disease is primary ciliary dyskinesia.